| MolName | (3E)-3-[[4-[(E)-2-[4-[(2E)-2-(4-carboxy-2,6-dioxopyridin-3-ylidene)hydrazinyl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]hydrazinylidene]-2,6-dioxopyridine-4-carboxylic acid |
| MolecularFormula | C26H18N6O14S2 |
| Smiles | OC(C(/C(/C(N1)=O)=N\Nc2cc(S(O)(=O)=O)c(/C=C/c(ccc(N/N=C(\C(C(O)=O)=CC(N3)=O)/C3=O)c3)c3S(O)(=O)=O)cc2)=CC1=O)=O |
| InChI | InChI=1S/C26H18N6O14S2/c33-19-9-15(25(37)38)21(23(35)27-19)31-29-13-5-3-11(17(7-13)47(41,42)43)1-2-12-4-6-14(8-18(12)48(44,45)46)30-32-22-16(26(39)40)10-20(34)28-24(22)36/h1-10,29-30H,(H,37,38)(H,39,40)(H,27,33,35)(H,28,34,36)(H,41,42,43)(H,44,45,46) |
| InChIK | HYCPIMRAYBQXML-UHFFFAOYSA-N |
| TotalMolweight | 702.589 |
| Molweight | 702.589 |
| MonoisotopicMass | 702.032244 |
| CLogP | -1.8308 |
| CLogS | -0.374 |
| H Acceptors | 20 |
| H Donors | 8 |
| TotalSurfaceArea | 462.78 |
| Relative PSA | 0.5546 |
| PolarSurfaceArea | 341.22 |
| Druglikeness | 1.9299 |
| Mutagenic | high |
| Tumorigenic | high |
| Reproductive Effective | none |
| Irritant | high |
| Nasty Functions | twice activated DB |
| Shape Index | 0.5 |
| Fragments | 1 |
| Non HAtoms | 48 |
| NonCHAtoms | 22 |
| Electronegative Atoms | 22 |
| Rotatable Bond | 10 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 6 |
| Symmetricatoms | 25 |
| Amides | 2 |
| AcidicOxygens | 4 |
| StereoCon |
Click to Load Molecule:
1 - (3E)-3-[[4-[(E)-2-[4-[(2E)-2-(4-carboxy-2,6-dioxopyridin-3-ylidene)hydrazinyl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]hydrazinylidene]-2,6-dioxopyridine-4-carboxylic acid | 2 - (3E)-3-[[4-[(E)-2-[4-[(2E)-2-(4-carboxy-2,6-dioxopyridin-3-ylidene)hydrazinyl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]hydrazinylidene]-2,6-dioxopyridine-4-carboxylic acid